Menu
/REGISTER
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'MannKind'
Latest

Revenue up at MannKind, but losses mount

By   /  Wednesday, May 12th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, Earnings, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Revenue up at MannKind, but losses mount

Westlake Village-based biotech company MannKind saw a slight bump in revenue in the first quarter thanks to its product Afrezza, but net losses continued to climb. MannKind released its earnings after the markets closed on May 12. It ended the day down 8.6% and regained 0.25% on May 13, to close at $4.03. MannKind, which Read More →

Read More →
Latest

MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback

By   /  Thursday, February 25th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, Earnings, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback

MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →

Read More →
Latest

MannKind beats earnings estimates

By   /  Thursday, May 7th, 2020  /  Biotech, Earnings, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind beats earnings estimates

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Tri-county stocks mixed as national indices drop slightly

By   /  Tuesday, April 28th, 2020  /  Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Tri-county stocks mixed as national indices drop slightly

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Most tri-county stocks end up for the day

By   /  Monday, April 27th, 2020  /  Biotech, Earnings, East Ventura County, Latest news, South Coast, Technology, Tri-County Public Companies, West Ventura County  /  Comments Off on Most tri-county stocks end up for the day

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Tri-county biotech firms tackle COVID-19 pandemic

By   /  Thursday, April 16th, 2020  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Tri-county biotech firms tackle COVID-19 pandemic

Life sciences companies in the Tri-Counties are stepping up with treatments for COVID-19, led by leaders in inhalable drug technologies. Westlake Village-based MannKind said it expects $4.9 million in forgivable loan relief as part of the CARES Act, passed in March, as it explores four potential anti-infective and antiviral therapies. Separately, aerosolized drug delivery company Read More →

Read More →
Latest

MannKind getting $5M loan to avoid layoffs and tackle COVID-19

By   /  Thursday, April 16th, 2020  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind getting $5M loan to avoid layoffs and tackle COVID-19

Westlake Village-based MannKind said it expects $4.9 million in federal forgivable loan relief, among other financial measures that will help it avoid furloughs and layoffs as it pursues potential therapies for the COVID-19 pandemic. The company is currently exploring four potential anti-infective and antiviral therapies, said CEO Michael Castagna.  “These are high risk areas and Read More →

Read More →